Healthy Life Agritec Ltd
Incorporated in 2019, Healthy Life Agritec Limited is in the business of trading milk, live poultry and
fresh meat products[1]
- Market Cap ₹ 48.6 Cr.
- Current Price ₹ 9.80
- High / Low ₹ 46.7 / 8.85
- Stock P/E 12.9
- Book Value ₹ 7.25
- Dividend Yield 0.00 %
- ROCE 13.3 %
- ROE 10.6 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 28.8%
- Company has a low return on equity of 9.85% over last 3 years.
- Debtor days have increased from 55.6 to 67.4 days.
- Promoter holding has decreased over last 3 years: -25.7%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|
| 34 | 108 | 133 | 172 | 186 | |
| 33 | 106 | 129 | 167 | 181 | |
| Operating Profit | 1 | 2 | 4 | 5 | 6 |
| OPM % | 4% | 2% | 3% | 3% | 3% |
| 0 | 0 | 0 | 0 | 0 | |
| Interest | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 2 | 3 | 4 | 5 |
| Tax % | 26% | 28% | 25% | 25% | |
| 1 | 2 | 3 | 3 | 4 | |
| EPS in Rs | 0.40 | 0.34 | 0.57 | 0.66 | 0.77 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 72% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 59% |
| TTM: | 30% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 37% |
| 1 Year: | -73% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 10% |
| Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 10 | 22 | 22 | 25 | 25 |
| Reserves | 1 | 2 | 5 | 10 | 11 |
| 1 | 1 | 3 | 8 | 8 | |
| 3 | 2 | 4 | 10 | 94 | |
| Total Liabilities | 15 | 27 | 34 | 52 | 137 |
| 2 | 2 | 2 | 2 | 6 | |
| CWIP | 0 | 0 | 0 | 3 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| 13 | 25 | 31 | 47 | 132 | |
| Total Assets | 15 | 27 | 34 | 52 | 137 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| -8 | -12 | -1 | -5 | |
| -2 | -1 | 0 | -4 | |
| 11 | 12 | 1 | 9 | |
| Net Cash Flow | 1 | -1 | -0 | -0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 30 | 31 | 68 | 67 |
| Inventory Days | 7 | 9 | 13 | 18 |
| Days Payable | 14 | 1 | 8 | 16 |
| Cash Conversion Cycle | 23 | 39 | 73 | 69 |
| Working Capital Days | 88 | 75 | 69 | 62 |
| ROCE % | 12% | 13% | 13% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16h - Newspaper Advertisment regarding Publication of standalone and consolidated Unaudited Financial Results for the quarter ended 31st December,2025 pursuent to regulation 30 and 47 of SEBI(Listing …
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
2d - Care Ratings Q3 (31-Dec-2025) monitoring: Rs24.81 crore rights issue; Rs21.75cr utilised, Rs3.06cr unutilised; no deviations.
- Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015 Held On Today I.E. 14Th February, 2026 2d
-
Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015 Held On Today I.E. 14Th February, 2026
2d - Q3/9M FY26 unaudited results approved; limited review; Rs.2,481.20 lakh rights issue; no fund deviation.
-
Board Meeting Intimation for Approval Of Financial Results For The Quarter Ended 31St December 2025 Pursuant To Regulation 29 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015.
10 Feb - Board meeting on 14 Feb 2026 to approve unaudited Q3 (Dec 31, 2025) results; trading window closed since 1 Jan.
Product Profile:
a) Dairy:[1]
Milk, Milk Powder, Milk Cream, Yogurt, Butter,
Cheese
b) Bakery:[2]
Bread, Buns, Croissant
c) Juices:[3]
Apple, Orange, Mango, Mixed Fruit